Perspective Therapeutics
CATX
48 hedge funds and large institutions have $13.9M invested in Perspective Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 17 closing their positions.
0.85% less ownership
Funds ownership: 13.13% → 12.28% (-0.85%)
16% less funds holding
Funds holding: 57 → 48 (-9)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
50% less capital inflows, than outflows
Capital inflows: $1.18M | Capital outflows: $2.34M
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$445K |
| 2 |
Perkins Capital Management
Wayzata,
Minnesota
|
+$223K |
| 3 |
Bard Associates
Chicago,
Illinois
|
+$135K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$118K |
| 5 |
Bank of New York Mellon
New York
|
+$65.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$595K |
| 2 |
BlackRock
New York
|
-$506K |
| 3 |
Bridgeway Capital Management
Houston,
Texas
|
-$228K |
| 4 |
Maven Securities
St Helier,
Jersey
|
-$167K |
| 5 |
Virtu Financial
New York
|
-$128K |
CATX Hedge Fund Activity: Q2 2021 in Review
48 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2021, worth a combined $13.9M — down 31% from $20.2M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CATX and 8 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was State Street, adding an estimated $445K. The largest seller was Renaissance Technologies, cutting an estimated $595K.
- 48 institutional investors held Perspective Therapeutics (CATX) as of Q2 2021, down from 57 in Q1 2021.
- Funds reported $13.9M of Perspective Therapeutics stock for Q2 2021, down 31% quarter-over-quarter.
- 8 funds opened new Perspective Therapeutics positions in Q2 2021 and 17 closed out, a net change of -9 holders.
- The largest Perspective Therapeutics buyer in Q2 2021 was State Street, an estimated $445K added.
- The largest Perspective Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $595K sold.
Based on aggregated 13F filings for Q2 2021.